Sunday, April 28, 2013

Drug Firms Face Value Questions

Biotechnology: Attendees at BIO convention confront new standards for patient outcomes



via Chemical & Engineering News: Biological SCENE http://feedproxy.google.com/~r/biological_scene/~3/4r3fDAlGgT8/Drug-Firms-Face-Value-Questions.html
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)